ID specialists as key stakeholders in OPAT market: ID specialists are the healthcare providers most frequently involved in identifying a patient for discharge on OPAT; nearly three-quarters (72 percent) of surveyed ID specialists indicated that their hospital requires prior consultation with an ID specialist to evaluate and setup patients for OPAT.
Not surprisingly, surveyed ID specialists reported being more likely to prescribe oral formulations of both Cubist's Sivextro (tedizolid) and Tetraphase's emerging drug eravacycline when discharging patients than OPAT with either drug, suggesting oral formulations of these agents will see greater use as discharge therapy.
Abbreviations: DEpiC = Diabetes Epidemiology Cohort, DSS = Decision Support System, EXT = extended care, FY = fiscal year, ICD-9 = International Classification of Diseases-9th Revision, LOS = length of stay, MHC = mental health condition, OBS = observation, OPAT
= outpatient file, VHA = Veterans Health Administration.
The data reinforce the efficacy of OPAT
even with the most serious of infectious presentations of MSSA, such as osteomyelitis, endocarditis, wound infections, and bacteremias.
Clinical outcomes recorded by the registry were determined by the physician responsible for the patient's care, who determined on the last day of OPAT
therapy whether the patient was improved, failed, or had no change.
Outpatient medical management with OPAT
included either the daily home care ($194) or infusion center fee ($154), insertion of PICC line with fluoroscopy ($786), PICC complications ($188), labs ($102), and physician office visit for evaluation of abSSTI ($222).
In the United States, OPAT
has become a widespread treatment practice due to its potential to reduce healthcare costs, improve convenience and patient satisfaction and decrease the risk of hospital-acquired infections.
Patient Peter Short of Guisborough, is using the OPAT
clinic after developing an infection in his thigh bone, said: "I can come here and then go home and have a normal life with my family rather than being sat in a hospital bed.
service, which treated its 1,000th patient in July 2010, treats people with chronic infected wounds and other deep seated infections as outpatients so they do not have to stay in hospital.
Nearly two-thirds of hospital-based physicians and almost half of office-based physicians expect to increase their use of Cubicin as OPAT
while Vibativ and Invanz will also see increased OPAT
usage, particularly by hospital-based physicians, albeit to a lesser degree than Cubicin.
, in certain situations, patients being treated for bacterial infections have the option of receiving a comparable standard of care in the comfort and convenience of their own home or in the physician's office -- which has been shown to increase patient satisfaction and ease the strain on hospital resources.
The treatment is outpatient intravenous/ intramuscular antibiotic therapy, or OPAT
, and new findings project it could potentially save Medicare $1.